Anti-Bevacizumab Mouse Monoclonal Antibody [clone: 11C1]
Catalog # 77007-476
Supplier: Genscript
Specifications
- Antigen Name:Bevacizumab
- Clonality:Monoclonal
- Clone:11C1
- Conjugation:Unconjugated
- ELISA:Yes
- Host:Mouse
- Isotype:IgG1 kappa
- Size:40 μg
- Cross Adsorption:No
- Form:Lyophilized
- Storage Buffer:Lyophilized with PBS, pH 7.2, containing 0.02% sodium azide
- Storage Temperature:The lyophilized product remains stable up to 1 year at −20 °C from date of receipt. Upon reconstitution, it can be stored for 2 - 3 weeks at 2...8 °C or for up to 12 months at −20 °C or below. Avoid freeze/thaw cycles
- Concentration:Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/ml
- Immunogen:Bevacizumab
- Tested Applications:Chemiluminescent immunoassay (CLIA)
- Cat. No.:77007-476
- Packaging:Vial
Specifications
About this item
Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of a number of types of cancers and a specific eye disease. Bevacizumab binds to a continuous epitope in VEGF, preventing interaction of VEGF with VEGFR on the surface of endothelial cells. It can be used to inhibit solid tumours growth and metastasis by weakening tumour angiogenesis.
- High specificity
- High affinity
- High stability
GenScript has developed a broad range of off-the-shelf anti-idiotype antibodies against blockbuster drugs to help accelerate your research of biosimilars.
Type:
Antigen: Bevacizumab
Clonality: Monoclonal
Clone: 11C1
Conjugation:
Epitope:
Host: Mouse
Isotype: IgG1 kappa
Reactivity: